Return to homepagePandemic Pact

Open clinical trial of the use of antioxidants and pentoxifylline as adjunctive therapy to improve the prognosis of patients with pneumonia and septic shock due to COVID-19.

  • Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Total publications:5 publications

Grant number: 312167

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Consejo Nacional de Ciencia y Tecnología (CONACYT)

  • Research Location

    Mexico

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Research, Development And Innovation Of Effective And Affordable Therapeutic Alternatives

5 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Preliminary Study on the Restoration of the Phospholipid Profile in Serum from Patients with COVID-19 by Treatment with Vitamin E.

Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study.

N-Acetyl Cysteine Restores the Diminished Activity of the Antioxidant Enzymatic System Caused by SARS-CoV-2 Infection: Preliminary Findings.

Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection.

Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19.